Holen Sie sich die Stockscreener-App
2.20
2.80%
0.06
Vorhandelsmarkt:
2.19
-0.01
-0.45%
Schlusskurs vom Vortag:
$2.14
Offen:
$2.12
24-Stunden-Volumen:
226.91K
Relative Volume:
1.62
Marktkapitalisierung:
$28.86M
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
+28.65%
1M Leistung:
+141.41%
6M Leistung:
-49.66%
1J Leistung:
+0.00%
1-Tages-Spanne:
$2.1072
$2.22
1-Wochen-Bereich:
$1.73
$2.22
52-Wochen-Spanne:
$0.69
$9.55
Scienture Holdings Inc Stock (SCNX) Company Profile
Firmenname
Scienture Holdings Inc
Sektor
Branche
Telefon
(800) 261 0281
Adresse
2420 BRUNELLO TRACE, LUTZ
Vergleichen Sie SCNX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
SCNX
Scienture Holdings Inc
|
2.20 | 22.43M | 0 | 0 | 0 | 0.00 |
|
WBA
Walgreens Boots Alliance Inc
|
11.54 | 9.96B | 151.95B | -5.78B | 571.00M | -6.69 |
|
HITI
High Tide Inc
|
2.40 | 188.00M | 376.07M | -22.41M | 18.73M | -0.298 |
|
WGRX
Wellgistics Health Inc
|
1.03 | 58.14M | 0 | 0 | 0 | 0.00 |
|
PETS
Petmed Express Inc
|
3.51 | 64.04M | 270.52M | -6.08M | 17.42M | -0.2944 |
Scienture Holdings Inc Aktie (SCNX) Neueste Nachrichten
Scienture Holdings Inc. Stock Analysis and ForecastRapid-fire capital growth - Autocar Professional
Is Scienture Holdings Inc. a good long term investmentConsistent high-yield stocks - Autocar Professional
What drives Scienture Holdings Inc. stock priceFree Investment Community - jammulinksnews.com
What analysts say about Scienture Holdings Inc. stockLightning-fast capital gains - Autocar Professional
Scienture Holdings regains compliance with Nasdaq listing requirements - MSN
Why did SCNX's Q2 2023 earnings exceed forecasts significantly? - AInvest
Scienture regains Nasdaq compliance as stock price exceeds $1 By Investing.com - Investing.com South Africa
Scienture regains Nasdaq compliance as stock price exceeds $1 - Investing.com
Scienture Holdings, Inc. Regains Compliance with Nasdaq Listing Requirements - The Manila Times
Scienture Meets $1 Nasdaq Requirement as FDA-Approved Drug Launch Approaches - Stock Titan
Why Scienture Holdings Inc. stock attracts strong analyst attentionHigh Return Intraday Picks - beatles.ru
How Scienture Holdings Inc. stock performs during market volatilityCapital Doubling Tips - Newser
What makes Scienture Holdings Inc. stock price move sharplyHigh Return Intraday Picks - Newser
Scienture Holdings Secures Indemnification for Leadership - The Globe and Mail
Is Scienture Holdings (NASDAQ:SCNX) Using Debt Sensibly? - simplywall.st
Scienture Holdings terminates equity line of credit ahead of product launch - Investing.com
Scienture Holdings Announces Cancelation of ELOC | SCNX Stock Ne - GuruFocus
Scienture Holdings Announces Cancelation of ELOC - The Manila Times
Scienture Holdings Announces Cancelation of ELOC | SCNX Stock News - GuruFocus
Scienture Holdings, Inc. Terminates Equity Line of Credit to Focus on Launching FDA-Approved Arbli - Nasdaq
Scienture Terminates $310M Credit Line to Focus on Revolutionary Liquid Hypertension Drug Launch - Stock Titan
Scienture appoints Hariharan, Mani as co-CEOs - MSN
SCIENTURE Appoint Dr. Shankar Hariharan and Dr. Narasimhan Mani as Co-CEO’s - citybiz
Scienture Appoints Co-CEOs as Suren Ajjarapu Steps Down - marketscreener.com
SCIENTURE Announces Executive Leadership Transition | SCNX Stock News - GuruFocus
SCIENTURE Announces Executive Leadership Transition - The Manila Times
Scienture Holdings, Inc. Announces Leadership Transition as Suren Ajjarapu Steps Down as CEO and Chairman - Nasdaq
Scienture Names Two Pharma Veterans as Co-CEOs in Strategic Leadership Overhaul - Stock Titan
SCIENTURE announces FDA Orange Book Patent Listing for ArbliTM, - GuruFocus
Scienture Holdings, Inc. Announces FDA Patent Listing for Arbli™, First FDA-Approved Liquid Losartan Formulation - Nasdaq
SCIENTURE announces FDA Orange Book Patent Listing for ArbliTM, (losartanpotassium) Oral Suspension, 10mg/mL. - The Manila Times
FDA Orange Book Milestone: First-Ever Liquid Losartan Secures Patent Protection Until 2041 - Stock Titan
Long-Term Bull Put Spread Provides Opportunities for ARM Bulls - The Globe and Mail
ON Holding Surges, Leads High-End Retailers Into Reversal - The Globe and Mail
Scienture Holdings: Q1 Earnings Snapshot - CTPost
Finanzdaten der Scienture Holdings Inc-Aktie (SCNX)
Es liegen keine Finanzdaten für Scienture Holdings Inc (SCNX) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
2.21%
5.53%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):